Revolutionize Your Retinal Analysis: AI-Powered Efficiency is Here.
Stop wrestling with slow, manual OCT scan reviews. Discover MAHAMAIA – the intelligent platform that delivers rapid, AI-driven insights for neurodegenerative disease biomarker detection.
The Challenge: Is Your Retinal Analysis Holding You Back?
Many healthcare institutions face significant challenges with traditional OCT analysis methods.
Overwhelmed by Volume?
Are your specialists spending too much time on laborious manual OCT scan reviews, leading to bottlenecks and delayed insights?
Missing Critical Early Signs?
Do you lack the advanced AI tools to consistently detect subtle, early-stage biomarkers of neurodegenerative diseases hidden in complex OCT data?
Inefficient Workflows?
Are outdated processes and a lack of automation slowing down your research cycles or clinical decision-making?
The Cost of Delayed Analysis
Traditional OCT analysis methods can lead to:
- Delayed research findings and publications
- Missed early biomarkers of neurodegenerative diseases
- Inefficient use of specialist time and expertise
- Increased costs and reduced patient throughput
MAHAMAIA - Intelligent OCT Analysis, Simplified.
Transforming retinal analysis with cutting-edge AI technology.
Introducing MAHAMAIA
MAHAMAIA is a cutting-edge, AI-powered platform designed for hospitals, clinics, and research institutions seeking to transform their retinal OCT analysis. We leverage state-of-the-art Vision Transformer models (including RETFound with advanced Register Token technology) to bring speed, precision, and powerful new insights to your fingertips.
Our Mission
To empower you with efficient, AI-driven tools for earlier and more reliable detection of potential NDD biomarkers, ultimately improving research outcomes and paving the way for better patient care.
Unlock the Power of AI
MAHAMAIA brings advanced AI capabilities to your retinal analysis workflow.
Lightning-Fast Automated Analysis
Drastically reduce manual review time. Our system targets inference times of less than 5 seconds per scan, freeing up your experts for higher-value tasks.
- Process hundreds of scans in minutes
- Eliminate analysis bottlenecks
- Parallel processing architecture
Advanced AI-Driven Biomarker Detection
Identify potential NDD-related biomarkers (e.g., patterns indicative of Tau/Amyloid proxies, abnormal thinning) with AI precision that may be missed by the human eye alone.
- Detect subtle early-stage indicators
- Consistent analysis criteria
- Continuously improving AI models
Intuitive Web Platform & Dashboard
Seamlessly upload OCT scans, visualize results (including segmentation and biomarker indicators), and track analysis history through a user-friendly interface. No complex installations required.
- Cloud-based accessibility
- Interactive visualization tools
- Secure data management
Enhanced Data-Driven Insights
Gain deeper understanding from your OCT data, support clinical confidence, and accelerate your research with objective, quantifiable AI-generated metrics.
- Comprehensive analytical reports
- Longitudinal tracking capabilities
- Research-ready data export
How MAHAMAIA Works
Our streamlined process makes advanced AI analysis accessible to all users, regardless of technical expertise.
1. Upload
Securely upload your OCT scans via our web portal. Our platform accepts standard OCT file formats from major manufacturers, ensuring compatibility with your existing equipment.
2. Analyze
Our AI engine processes the scans rapidly, performing layer segmentation and biomarker detection. The advanced Vision Transformer models work in parallel to deliver comprehensive analysis in seconds rather than hours.
3. Visualize & Report
Access comprehensive results, including visual overlays and quantitative data, on your dashboard. Export detailed reports for integration with your existing systems or for sharing with colleagues.
Technology Behind MAHAMAIA
Leveraging cutting-edge AI to transform retinal analysis.
State-of-the-Art Vision Transformer Models
MAHAMAIA leverages cutting-edge AI technology specifically optimized for retinal OCT analysis.
RETFound Implementation
Our platform utilizes the powerful RETFound architecture, pre-trained on millions of retinal images to recognize subtle patterns invisible to the human eye.
Register Token Technology
Advanced Register Token technology enables precise spatial awareness within OCT scans, allowing for accurate layer segmentation and biomarker localization.
Continuous Learning System
Our AI models continuously improve through federated learning techniques, incorporating new insights while maintaining strict patient privacy.
Join Our Exclusive MVP Pilot Program
Be among the first to experience the future of retinal analysis.
Be at the Forefront of Innovation
Partner with us as an early adopter of MAHAMAIA. Your feedback will directly influence the development of a transformative tool for NDD research and diagnostics.
Experience the Benefits Firsthand
Evaluate MAHAMAIA within your own workflow with our attractive pilot program pricing.
Shape the Future
Your feedback will directly influence the development of a transformative tool for NDD research and diagnostics.
Priority Access
Get early access to new features and updates before they're widely available.
Pilot Program Timeline
Onboarding (Weeks 1-2)
- Platform access setup
- Training sessions for your team
- Initial system configuration
Implementation (Weeks 3-8)
- Integration with your workflow
- Regular check-ins with our support team
- Performance monitoring and optimization
Evaluation & Feedback (Weeks 9-12)
- Comprehensive performance review
- Feedback collection and analysis
- Discussion of long-term partnership options
Transformative Use Cases
Discover how MAHAMAIA can transform retinal analysis across different settings.
Research Institution Applications
MAHAMAIA is designed to help neurodegenerative disease research centers streamline their OCT analysis workflow and uncover new insights from retinal data.
Accelerated Analysis Process
Our AI-powered platform aims to dramatically reduce the time required for OCT scan analysis, potentially freeing up researchers to focus on higher-value tasks and accelerating research timelines.
Enhanced Biomarker Detection
MAHAMAIA's advanced algorithms are designed to identify subtle biomarkers that might be missed in manual review, potentially leading to new discoveries in neurodegenerative disease research.
Streamlined Research Workflow
By automating repetitive analysis tasks, our platform aims to help research teams process larger datasets more efficiently, potentially accelerating publication timelines and research output.
Potential Benefits
- Process thousands of historical OCT scans in a fraction of the time
- Identify potential new correlations between retinal biomarkers and cognitive decline
- Reduce specialist analysis time from hours to minutes per scan
- Accelerate research publication timelines through faster data processing